Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-063804

ImmunityBio, Inc. · IBRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Patrick Soon-Shiong
Officer — Chairman and CEO · Director · 10% Owner
Period of report
Jul 27, 2015
Accepted (ET)
Aug 4, 2015 · 6:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 27, 2015A600,000$0.00A600,000D
Common StockF2holding———40,566,557ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F3$25.00Jul 27, 2015A900,000A—Jul 27, 2025Common Stock900,000900,000D

Explanation of responses